Writing Samples

Ophthalmology manuscripts

Dohar JE, Roland P, Wall GM, McLean C, Stroman DW. Differences in bacteriologic treatment failures in acute otitis externa between ciprofloxacin/dexamethasone and neomycin/polymyxin B/hydrocortisone: results of a combined analysis. Curr Med Res Opin. 2009;25:287-91. PMID: 19192973

Hariprasad SM, Akduman L, Clever JA, Ober M, Recchia FM, Mieler WF. Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%. Clin Ophthalmol. 2009;3:147-54. PMID: 19668559

Katz G, Dubiner H, Samples J, Vold S, Sall K. Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.JAMA Ophthalmol. 2013;131:724-30. PMID: 23579344

Lindstrom R, Lane S, Cottingham A, Smith S, Sall K, Silverstein S, Shettle L, Walters T, Faulkner R, Cockrum P, Teuscher N. Conjunctival concentrations of a new ophthalmic solution formulation of moxifloxacin 0.5% in cataract surgery patients. J Ocul Pharmacol Ther. 2010;26:591-5. PMID: 20925517

Maxwell WA, Cionni RJ, Lehmann RP, Modi SS. Functional outcomes after bilateral implantation of apodized diffractive aspheric acrylic intraocular lenses with a +3.0 or +4.0 diopter addition power Randomized multicenter clinical study. J Cataract Refract Surg. 2009;35:2054-61. PMID: 19969208

Scoper SV. Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy. Adv Ther. 2008;25:979-94. Review. PMID: 18836691

Stringer W, Bryant R. Dose uniformity of topical corticosteroid preparations: difluprednate ophthalmic emulsion 0.05% versus branded and generic prednisolone acetate ophthalmic suspension 1%. Clin Ophthalmol. 2010;4:1119-24. PMID: 20957058

Thiel MA, Wild A, Schmid MK, Job O, Bochmann F, Loukopoulos V, Alcantara W, Schmidt A, Lichtlen P, Escher D. Penetration of a topically administered anti-tumor necrosis factor alpha antibody fragment into the anterior chamber of the human eye. Ophthalmology. 2013;120:1403-8. PMID: 23490328

Walters T, Raizman M, Ernest P, Gayton J, Lehmann R. In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. J Cataract Refract Surg. 2007;33:1539-45. PMID: 17720067

Oncology manuscripts

Glück S, Mamounas T. Improving outcomes in early-stage breast cancer. Oncology (Williston Park). 2010;24(11 Suppl 4):1-15.  PMID: 21284351

Klem J. Current studies with PTK787, an oral inhibitor of vascular endothelial growth factor in colorectal cancer. Clin Colorectal Cancer. 2003;3:147-9. Review. PMID: 14706172

Klem J. Gene expression profiling to predict outcome of chemotherapy for early-stage breast cancer. Clinical Breast Cancer. August 2003. Available at:
http://cigjournals.metapress.com/content/3826704w26944327/fulltext.pdf

Mita AC, Takimoto CH, Mita M, Tolcher A, Sankhala K, Sarantopoulos J, Valdivieso M, Wood L, Rasmussen E, Sun YN, Zhong ZD, Bass MB, Le N, LoRusso P. Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors. Clin Cancer Res. 2010;16:3044-56. PMID: 20501621

Patient materials

A patient’s guide to mesothelioma. Note: only selected chapters written by Jennifer Klem. Available at: http://www.curetoday.com/assets/documents/pocketguide_mesothelioma.pdf

Klem J. Taking a chance on stem cell transplantation. Cure. Winter 2012. Available at: http://www.curetoday.com/index.cfm/fuseaction/article.show/id/2/article_id/2020


Klem Medical Communications, LLC
Coppell, TX 75019
Website Builder